A quantitative study of radionuclide characteristics for radioimmunotherapy from 3D reconstructions using serial autoradiography

International Journal of Radiation Oncology Biology Physics

Volumn 35, Issue 1, 1996, Pages 165-172

  Muthuswamy, Moorthy S ^a,c   Roberson, Peter L ^a   Ten Haken, Randall K ^a   Buchsbaum, Donald J ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b The University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

131Iodine labeled monoclonal antibodies; Antibodies; Colon cancer; Dosimetry; Quantitative autoradiography; Radioimmunotherapy; Radiolabeled antibodies; Radionuclides

Indexed keywords

MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BONE MARROW CELL; COLON CANCER; DOSE RESPONSE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RADIATION DOSE; RADIOIMMUNOTHERAPY; TUMOR VOLUME;

EID: 0029986422     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)85026-7     Document Type: Article

References (28)

1. Attix, F. H.; Roesch, W. C.; Tochilin, E. Radiation Dosimetry. vol 3. Academic Press; 1966.
2. 90Y-labeled immunoconjugate. Cancer 73(3):958-965; 1994.
3. Buchsbaum, D. J.; Brubaker, P. G.; Hanna, D. E.; Glatfelter, A. A.; Terry, V. H.; Gibault, D. M.; Steplewski, Z. Comparative binding and preclinical localization and therapy studies with radiolabeled human chimeric and murine 17-1A monoclonal antibodies. Cancer Res. Suppl. 50:9935-9995; 1990.
4. 131I-labeled monoclonal antibody 17-1A treatment to external beam irradiation on the growth of LS174T human colon carcinoma xenografts. Int. J. Radiat. Oncol. Biol. Phys. 18:1033-1041; 1990.
5. Esteban, J. M.; Schlom, J; Gansow, O. A.; Atcher, R. W.; Brechbiel, M. W.; Simpson, D. E.; Colcher, D. New method for the chelation of indium-111 to monoclonal antibodies: Biodistribution and imaging of athymic mice bearing human colon carcinoma xenografts. J. Nucl. Med. 28:861-870; 1987.
6. Fowler, J. F. Radiobiological aspects of low dose rates in radioimmunotherapy. Int. J. Radiat. Oncol. Biol. Phys. 18:1261-1269; 1990.
7. 186Re-labeled NR-LU-10 whole antibody in LS174T colonie tumor-bearing mice. Cancer Res. 50:7973-7978; 1990.
8. Griffiths, G. L.; Goldenberg, D. M.; Jones, A. L.; Hausen, H. J. Radiolabeling of monclonal antibodies and fragments with technetium and rhenium. Bioconjugate Chem. 3:91-99; 1992.
9. Hui, T. E.; Fisher, D. R.; Kuhn, J. A.; Williams, L. E.; Nourigat, C.; Badger, C. C.; Beatty, B. G.; Beatty, J. D. A mouse model for calculating cross organ beta doses for Yttrium-90-labeled immunoconjugates. Cancer 73:951-957; 1994.
10. Kozak, R. W.; Raubitschek, A.; Mirzadeh, S.; Brechbiel, M. W.; Junghaus, R.; Gansow, O. A.; Waldmann, T. A. Nature of bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: Critical factors in determining in vivo survival and organ toxicity. Cancer Res. 49:2639-2644; 1989.
11. 131I-labeled antibody in multicell spheriods. Int. J. Radiat. Oncol. Biol. Phys. 24:127-132; 1992.
12. Langmuir, V. K.; Fowler, J. F.; Knox, S. J.; Wessels, B. W.; Sutherland, R. M.; Wong, J. Y. C. Radiobiology of radiolabeled antibody therapy as applied to tumor dosimetry. Med. Phys. 20:601-610; 1993.
13. Loevinger, R.; Japha, E. M.; Brownell, G. L. Discrete radioisotope sources. In: Hine, G. J.; Brownell, G. L., eds. Radiation dosimetry. New York: Academic Press; 1956:693-799.
14. Loevinger, B.; Berman, M. A. Revised schema for calculating the absorbed dose from biologically distributed radionuclides. Medical Internal Radiation Dose (MIRD) Pamphlet No. 1 Revised. New York: Society of Nuclear Medicine; 1976.
15. Mausner, M. L.; Srivastava, S. C. Selection of radionuclides for radioimmunotherapy. Med. Phys. 20:503-509; 1993.
16. Prestwich, W. V.; Nunes, J.; Kwok, C. S. Beta dose point kernels for radionuclides of potential use in radioimmunotherapy. J. Nucl. Med. 30:1036-1046; 1989; 30:1739- 1740; 1989.
17. Prestwich, W. V.; Nunes, J.; Kwok, C. S. Beta dose point kernels for radionuclides of potential use in radioimmunotherapy. J. Nucl. Med. 30:1036-1046; 1989; 30:1739-1740; 1989.
18. 131iodine-labeled monoclonal antibody. Antibody Immunoconjug. Radiopharmacol. 3:397-402; 1992.
19. Roberson, P. L.; Buchsbaum, D. J.; Heidorn D. B.; Ten Haken, R. K. Three-dimensional tumor dosimetry for radioimmunotherapy using serial autoradiography. Int. J. Radiat. Oncol. Biol. Phys. 34:329-334; 1992.
20. Roberson, P. L.; Heidorn, D. B.; Kesseler, M. L.; Ten Haken, R. K.; Buchsbaum, D. J. Three dimensional reconstruction of monoclonal antibody uptake in tumor and calculation of beta dose-rate nonuniformity. Cancer 73(3):912-918; 1994.
21. Roselli, M.; Schlom, J.; Gansow, O. A.; Raubitschek, A.; Mirzadeh, S.; Brechbiel, M. W.; Colcher, D. Comparative biodistributions of yttrium- and indium-labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenografts. J. Nucl. Med. 30:672-682; 1989.
22. Sharkey, R. M.; Motta-Hennessy, C.; Paulyk, D.; Siegel, J. A.; Goldenberg, D. M. Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human colonic tumor xenografts. Cancer Res. 50:2330-2336; 1990.
23. Siegel, J. A.; Wessels, B. W.; Watson, E. E.; Stabin, M. G.; Vriesendoerp, H. M.; Bradley, E. W.; Badger, C. C.; Brill, A. B.; Kwok, C. S.; Stickney D. R.; Eckerman, K. F.; Fischer, D. R.; Buchsbaum, D. J.; Order, S. E. Bone marrow dosimetry and toxicity for radioimmunotherapy. Antibody Immunoconjug. Radiopharmacol. 3:213-233; 1990.
24. Snyder, W. S.; Ford, M. R.; Warner, G. G.; Watson, S. B. Absorbed dose per unit activity for selected radionuclides and organs. Medical Internal Radiation Dose (MIRD), Pamphlet No. 11. New York: Society of Nuclear Medicine; 1975:5-257.
25. Wessels, B. W.; Rogus, R. P. Radionuclide selection and model absorbed dose calculations for radiolabeled tumor associated antibodies. Med. Phys. 11:638-645; 1984.
26. 90Y. Radiother. Oncol. 21:91-99; 1991.
27. Williams, L. E.; Duda, R. B.; Proffitt, R. T.; Beatty, J. D.; Wong, J. Y. C. Tumor uptake as a function of tumor mass: A mathematical model. J. Nucl. Med. 29:103-109; 1988.
28. Yorke, L. D.; Beaumier, P. L.; Wessels, B. W.; Fritzberg, A. R.; Morgan, C. A. Optimal antibody-radionuclide combinations for clinical radioimmunotherapy: A predictive model based on mouse pharmacokinetics. Nucl. Med. Biol. 18:827-835; 1991.